Gabriel Lopez

Gabriel Lopez

Y Combinator Logo Batch: S16

Achievements

  • Co-invented core biotech tech while pursuing Ph.D. at UC Berkeley
  • Founded Synvivia in 2015, participated in Y Combinator 2016 cohort
  • Developed genetically encoded biocontainment and ON-OFF switches for engineered organisms
  • Secured NSF, DARPA grants and funding from NIH, Y Combinator, and industry partners
  • Led research in protein engineering and biosafety at UC Berkeley, Professor John Anderson’s lab
  • Prior experience at Siemens Healthcare, active in Berkeley iGEM team

This is Gabriel Lopez

Bruh, listen up about Gabriel Lopez, the real deal in biotech startup land. This guy’s story is straight-up inspiring. So, he’s the founder and CEO of Synvivia, a badass synthetic biology company outta Berkeley. But it’s not just some random startup, he’s the guy who co-invented the core tech that makes it all happen while he was deep in his Ph.D. at UC Berkeley. Think about that, while most people are just trying to graduate, he’s over here building stuff that could change biotech forever.

Gabriel’s background is stacked. He’s been around the block with UC Berkeley, Berkeley iGEM (yeah, that’s the big international synthetic biology competition), and even worked at Siemens Healthcare. So, he’s no stranger to the lab, the industry, or the hustle. His research in protein engineering and genetically encoded biosafety stuff? Next level. He was in Professor John Anderson’s lab, really pushing the boundaries on safety and control in biotech, stuff that’s super critical when you’re talking about gene therapy and pharma.

Now, here’s where it gets interesting. In 2015, he jumps into founding Synvivia, no cap, that’s the same year he’s still grinding on his Ph.D. The company’s all about genetically encoded biocontainment tech and ON-OFF switches for engineered organisms, basically, giving scientists and companies the tools to make biotech safer, more controlled, and expandable. And get this, they tapped into grants from NSF and DARPA, plus funding from YC (they crushed it in S16), NIH, and some industry partners. That’s legit validation that what they’re doing is the real deal.

Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.

Talk to her

What I really respect about Gabriel is his sharp focus on IP and protecting deep tech. He understands that in biotech, patents are everything, that’s how you build something sustainable and defend your edge. His process shows he’s all about turning science into something that’s not only original but also commercially viable, protected, and effective.

So, what does all this say about him? Dude’s motivated by pushing the boundaries of what’s possible in biotech, but also making it safe and practical. His whole career screams that he’s not just in it for the tech, he’s out here trying to solve real problems, like biosafety, that matter big time. And he’s doing it by jumping into complicated, tough tech, and then figuring out how to make it stick in the real world.

Long story short, Gabriel Lopez is a nerd with a mission. He’s the guy who took his hardcore research and turned it into a startup that could seriously shape how biotech is done in the future. He’s the kind of founder who’s not just chasing the dollar but genuinely trying to make a difference. That’s why he’s so important.

Founder ID: 106802

Share your thoughts about Gabriel Lopez

Have you worked with this founder? Know additional information? Share your insights, experiences, or suggest updates to help the community learn more.

Select your comment type:

Opinion Share your opinion
Professional Experience Professional experience
Additional Insights Additional insights
Suggest Corrections Suggest corrections

If something is wrong about Gabriel Lopez, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)

Your email address will not be published. Help us build a comprehensive founder database.